Yale researchers have discovered how metastasis, the spread of cancer cells throughout the body, is triggered on the molecular level, and have developed a tool with the potential to detect those triggers in patients with ...
Jun 26, 2019
0
0
University of Alberta researchers have added a new genetic marker to the breast cancer map, helping to expand the list of genetic mutations clinicians can watch for in cancer screenings.
Jun 20, 2019
0
0
Researchers with the Atlanta Veterans Affairs Medical Center and Emory University have found a link between high LDL cholesterol levels and early-onset Alzheimer's disease. The results could help doctors understand how the ...
May 28, 2019
2
780
(HealthDay)—The first personalized treatment for patients with metastatic bladder cancer and susceptible fibroblast growth factor receptor (FGFR) genetic alterations was granted accelerated approval by the U.S. Food and ...
Apr 15, 2019
0
1
Genes play a role in determining the beauty of a person's face, but that role varies with the person's sex, according to a new study by Qiongshi Lu and colleagues at the University of Wisconsin-Madison, published 4th April ...
Apr 4, 2019
0
214
A powerful analytical tool, known as UTMOST, developed by Hongyu Zhao, Ph.D., the Ira V. Hiscock Professor of Biostatistics at the Yale School of Public Health, and colleagues could allow researchers to design therapeutic ...
Mar 15, 2019
0
0
A new class of oral cholesterol-lowering drug could help patients unable to take statins due to side effects.
Mar 13, 2019
0
367
Having a genetic predisposition to high testosterone levels could play a role in the development of major heart problems in men, such as blood clots and heart failure, finds a study published by The BMJ today.
Mar 6, 2019
0
80
There is more to consider than just cholesterol levels when it comes to cardiovascular health. Experts at Baylor College of Medicine say even if you have lowered your cholesterol and have been prescribed statins, new data ...
Feb 28, 2019
0
90
A study led by researchers at Cardiff University means that more people of African descent who have treatment-resistant schizophrenia could be safely given the drug best proven to manage their symptoms.
Feb 26, 2019
0
5
